Long noncoding RNA Chast promotes cardiac remodeling
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Inhibition of the long noncoding RNA Chast prevents pressure overload–induced cardiac remodeling in mice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Epigenetic manipulation through long non-coding RNAs, miRNA modulators, and other oligonucleotides has yielded promising outcomes in experimental settings.162–165”
From Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis (2020) · cites this paper as [163]
Citations
Cites
1 retracted
Rockman, H. A., Ross, R. S., Harris, A. N., Knowlton, K. U., Steinhelper, M. E., Field, L. J., Ross, J., & Chien, K. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.18.8277 · Cited by 797 · cited 1×
“To generate cardiac pressure overload, male C57BL/6N mice (8 to 10 weeks old) were subjected to TAC as described previously (29).”
MethodRetractedAn integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs
Rinn, J. L., Kertesz, M., Wang, J. K., Squazzo, S. L., Xu, X., Brugmann, S. A., Goodnough, L. H., Helms, J. A., Farnham, P. J., Segal, E., et al. (2007) · Cell · doi:10.1016/j.cell.2007.05.022 · Cited by 4,244 · cited 1×
“LncRNAs regulate pathways by diverse mechanisms including chromatin modification (3), transcriptional (4) and posttranscriptional regulation (5), and influencing subcellular trafficking (6, 7).”
BackgroundGenome Regulation by Long Noncoding RNAs
Rinn, J. L., & Chang, H. Y. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-051410-092902 · Cited by 4,005 · cited 1×
“LncRNAs can function as guide strands influencing genes or proteins in trans (on distantly located genes) or in cis (on neighboring genes) (23).”
BackgroundOpen source clustering software
de Hoon, M. J. L., Imoto, S., Nolan, J., & Miyano, S. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth078 · Cited by 3,043
Java Treeview—extensible visualization of microarray data
Saldanha, A. J. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth349 · Cited by 2,991
Kong, L., Zhang, Y., Ye, Z.-Q., Liu, X.-Q., Zhao, S.-Q., Wei, L., & Gao, G. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm391 · Cited by 2,803
A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy
Molkentin, J. D., Lu, J.-R., Antos, C. L., Markham, B., Richardson, J., Robbins, J., Grant, S. R., & Olson, E. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81573-1 · Cited by 2,566 · cited 2×
“To determine whether Chast is regulated by NFAT activation, we tested Chast expression in hearts of calcineurin (Myh6-CnA) transgenic (TG) mice (15), where NFAT is constitutively active.”
BackgroundMethodLian, X., Zhang, J., Azarin, S. M., Zhu, K., Hazeltine, L. B., Bao, X., Hsiao, C., Kamp, T. J., & Palecek, S. P. (2013) · Nature Protocols · doi:10.1038/nprot.2012.150 · Cited by 1,748
Cited by
Items 101–200 of 369
Zhang, M., Jiang, Y., Guo, X., Zhang, B., Wu, J., Sun, J., Liang, H., Shan, H., Zhang, Y., Liu, J., et al. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14641 · Cited by 51
Xie, L., Zhang, Q., Mao, J., Zhang, J., & Li, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.680713 · Cited by 53
Okuyan, H. M., & Begen, M. A. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.05.030 · Cited by 51
Knocking Down Long Noncoding RNAs Using Antisense Oligonucleotide Gapmers
Maruyama, R., & Yokota, T. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0771-8_3 · Cited by 50
Long Noncoding RNAs: New Players in Ischaemia-Reperfusion Injury
Yu, S., Tang, L., & Zhou, S. (2017) · Heart Lung and Circulation · doi:10.1016/j.hlc.2017.09.011 · Cited by 47
“cardiac hypertrophy with improved heart function [76].”
Expression Profile of Long Noncoding RNAs, lnc-Cox2, and HOTAIR in Rheumatoid Arthritis Patients
Shaker, O. G., Mahmoud, R. H., Abdelaleem, O. O., Ahmed, T. I., Fouad, N. A., Hussein, H. A., Nassr, M., Zaki, O. M., Abdelghaffar, N. K., & Hefzy, E. M. (2019) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2018.0117 · Cited by 46
Mably, J. D., & Wang, D. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00952-5 · Cited by 46
Expanding the horizon of EV-RNAs: LncRNAs in EVs as biomarkers for disease pathways
Spanos, M., Gokulnath, P., Chatterjee, E., Li, G., Varrias, D., & Das, S. (2023) · Extracellular Vesicle · doi:10.1016/j.vesic.2023.100025 · Cited by 47
Noncoding RNAs in Heart Failure
Dangwal, S., Schimmel, K., Foinquinos, A., Xiao, K., & Thum, T. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_99 · Cited by 46
“This study pioneered the field describing Chrf (cardiac hypertrophy-related factor), an lncRNA that is induced in vitro in cardiomyocytes after treatment with angiotensin II, in pressure overload-induced cardiac hypertrophy in a murine TAC model as well as in human heart failure samples, underscoring translational rel…”
BackgroundInfluentialSelf-citationRey, F., Urrata, V., Gilardini, L., Bertoli, S., Calcaterra, V., Zuccotti, G., Cancello, R., & Carelli, S. (2021) · Obesity Reviews · doi:10.1111/obr.13203 · Cited by 46
Mechanotranduction Pathways in the Regulation of Mitochondrial Homeostasis in Cardiomyocytes
Liao, H., Qi, Y., Ye, Y., Yue, P., Zhang, D., & Li, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.625089 · Cited by 47
Inhibition of HIPK2 protects stress-induced pathological cardiac remodeling
Zhou, Q., Meng, D., Li, F., Zhang, X., Liu, L., Zhu, Y., Liu, S., Xu, M., Deng, J., Lei, Z., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104274 · Cited by 45
The Role of Non-Coding RNA in Congenital Heart Diseases
Dueñas, Á., Expósito, A., Aránega, A. E., & Franco, D. (2019) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd6020015 · Cited by 45
“Several lcnRNAs have been reported to play fundamental role in distinct cardiac pathological conditions, such as Myheart and Chaer in cardiac hypertrophy [105,118]; Crnde, Homeobox A11, Wisper and MEG3 in cardiac fibrosis [119–122]; and Charme and Chast in cardiac remodeling [123,124] (Figure 2).”
BackgroundNoncoding RNAs in Cardiac Hypertrophy and Heart Failure
Lu, P., Ding, F., Xiang, Y. K., Hao, L., & Zhao, M. (2022) · Cells · doi:10.3390/cells11050777 · Cited by 47
“The lncRNA Chast negatively regulates the expression of the autophagy regulator Pleckstrin homology domain-containing protein family M member 1 (Plekhm1) to drive hypertrophy [90].”
BackgroundTalebian, S., Daghagh, H., Yousefi, B., Özkul, Y., Ilkhani, K., Seif, F., & Alivand, M. R. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111309 · Cited by 48
Long Noncoding RNAs in Pathological Cardiac Remodeling
Viereck, J., & Thum, T. (2017) · Circulation Research · doi:10.1161/circresaha.116.310174 · Cited by 41
“Despite a broad interest in lncRNAs, only a handful of transcripts have been well studied including regulators of cardiomyocyte differentiation like Braveheart(4) and Fendrr(5) or noncoding actors in cardiac remodeling like Myheart(6) or Chast.(7) We still know little about how lncRNAs act at the molecular level and t…”
Self-citationExpedition to the missing link: Long noncoding RNAs in cardiovascular diseases
Yeh, C., Chang, Y.-C. E., Lu, C.-Y., Hsuan, C., Chang, W., & Yang, K. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00647-w · Cited by 45
“Chast [29] Plekhm1 Promotes cardiac hypertrophy Activated by NFAT signaling and downregulates Plekhm1 to induce cardiac remodeling processes”
BackgroundA lncRNA Perspective into (Re)Building the Heart
Frank, S., Aguirre, A., Hescheler, J., & Kurian, L. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00128 · Cited by 40
“…et al., 2015a CHAST Mouse/Human Antisense Pro-hypertrophic; cis-regulation chr17:64,783,199–64,783,552 (human) chr11:103,363,213–103,364,651 (mouse) Viereck et al., 2016 Chrf Mouse Intergenic Cardiac hypertrophy; miRNA sponge chr18:72164057–72165898 Wang et al., 2014a Fendrr Mouse/Human…”
Non‐coding RNAs: key players in cardiac disease
Kreutzer, F. P., Fiedler, J., & Thum, T. (2019) · The Journal of Physiology · doi:10.1113/jp278131 · Cited by 41
Self-citationThe function of LncRNA-H19 in cardiac hypertrophy
Su, W., Huo, Q., Wu, H., Wang, L., Ding, X., Liang, L., Zhou, L., Zhao, Y., Dan, J., & Zhang, H. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00668-4 · Cited by 42
Chromatin remodelling and epigenetic state regulation by non-coding RNAs in the diseased heart
Majo, F. D., & Calore, M. (2018) · Non-coding RNA Research · doi:10.1016/j.ncrna.2018.02.003 · Cited by 42
Bhattacharyya, N., Pandey, V., Bhattacharyya, M., & Dey, A. (2021) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2021.02.006 · Cited by 48
A high-throughput screen identifies the long non-coding RNA DRAIC as a regulator of autophagy
Tiessen, I., Abildgaard, M. H., Lubas, M., Gylling, H. M., Steinhauer, C., Pietras, E. J., Diederichs, S., Frankel, L. B., & Lund, A. H. (2019) · Oncogene · doi:10.1038/s41388-019-0783-9 · Cited by 42
Bei, Y., Wang, H., Liu, Y., Su, Z., Li, X., Zhu, Y., Zhang, Z., Yin, M., Chen, C., Li, L., et al. (2024) · Research · doi:10.34133/research.0327 · Cited by 45
“The hESCs were cultured and differentiated to cardiomyocytes as previously reported [61].”
MethodAnti-ageing interventions for the treatment of cardiovascular disease
Abdellatif, M., Schmid, S., Fuerlinger, A., & Kroemer, G. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae177 · Cited by 52
“34,35 Similarly, cardiac overexpression of the long ncRNA Mhrt779 attenuated pathological remodelling and dysfunction in female and male mice subjected to pressure overload by trans-aortic constriction.”
Therapeutic targeting of autophagy in myocardial infarction and heart failure
Riquelme, J. A., Chávez, M. N., Mondaca‐Ruff, D., Bustamante, M., Vicencio, J. M., Quest, A. F. G., & Lavandero, S. (2016) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2016.1202760 · Cited by 38
Targeting LncRNAs in Cardiovascular Disease
Haemmig, S., & Feinberg, M. W. (2017) · Circulation Research · doi:10.1161/circresaha.116.310152 · Cited by 37
Leti, F., Morrison, E. J., & DiStefano, J. K. (2017) · Personalized Medicine · doi:10.2217/pme-2016-0107 · Cited by 38
Non-coding RNA-linked epigenetic regulation in cardiac hypertrophy
Dong, Y., Xu, S., Liu, J., Ponnusamy, M., Zhao, Y., Zhang, Y. H., Wang, Q., Li, P., & Wang, K. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.26215 · Cited by 43
“For instance, Chast and PVT1 are sufficient to promote cardiac hypertrophy [80, 81].”
BackgroundZhou, J., Zhou, Y., & Wang, C. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28001 · Cited by 39
“In contrary, miR‐29 could also protect the body against fibrosis by blocking collagen release from the extracellular matrix.(9) Unlike miRNAs, long noncoding RNAs (lncRNAs) are a type of RNA transcripts containing more than 200 nucleotides.”
BackgroundYang, Y., Mbikyo, M. B., Zhang, J., Zhang, Y., Zhang, N., & Li, Z. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-00977-8 · Cited by 37
“Cardiac Hypertrophy-Associated Transcript (Chast) was upregulated in both mouse TAC model and aortic stenosis patients [9].”
BackgroundCollins, L., Binder, P., Chen, H., & Wang, X. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00798 · Cited by 41
“GapmeR-mediated silencing has been used to downregulate the lncRNA Chast, which mediates cardiac hypertrophy in vivo in mice and human cells in vitro (Viereck et al., 2016).”
MethodLong Noncoding RNAs as Therapeutic Targets
Pierce, J. B., Zhou, H., Simion, V., & Feinberg, M. W. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-92034-0_9 · Cited by 41
Navigating the non-coding genome in heart development and Congenital Heart Disease
Chahal, G., Tyagi, S., & Ramialison, M. (2019) · Differentiation · doi:10.1016/j.diff.2019.05.001 · Cited by 31
Zhang, Q., Wang, F., Wang, F., & Wu, N. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28964 · Cited by 35
“For example, lncRNA Chast influences CH via promoting cardiac remodeling (Viereck et al., 2016).”
BackgroundClinical value of non-coding RNAs in cardiovascular, pulmonary, and muscle diseases
Bonnet, S., Boucherat, O., Paulin, R., Wu, D., Hindmarch, C. C. T., Archer, S. L., Song, R., Moore, J. B., Provencher, S., Zhang, L., et al. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00078.2019 · Cited by 35
LncRNA KCNQ1OT1 contributes to cardiomyocyte apoptosis by targeting FUS in heart failure
Lai, L., Xu, Y., Kang, L., Yang, J., & Zhu, G. (2020) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2020.104480 · Cited by 35
Kitow, J., Derda, A. A., Beermann, J., Kumarswarmy, R., Pfanne, A., Fendrich, J., Lorenzen, J. M., Xiao, K., Bavendiek, U., Bauersachs, J. K., et al. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00194.2016 · Cited by 35
“(21) demonstrated a cardiac hypertrophy-associated transcript, named Chast, leading to cardiac hypertrophy in mice by negatively regulating Pleckstrin homology domain 1.”
BackgroundSelf-citationMeydan, C., Bekenstein, U., & Soreq, H. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00189 · Cited by 37
“The CHAST lncRNA is upregulated in cardiomyocytes during hypertrophic heart disease (Viereck et al., 2016).”
BackgroundSong, C., Qi, H., Liu, Y., Chen, Y., Shi, P., Zhang, S., Ren, J., Wang, L., Cao, Y., & Sun, H. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.10.024 · Cited by 34
The salient role of microRNAs in atherogenesis
Donaldson, C. J., Lao, K. H., & Zeng, L. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.08.004 · Cited by 32
Kumar, A., Girisa, S., Alqahtani, M. S., Abbas, M. A. E., Hegde, M., Sethi, G., & Kunnumakkara, A. B. (2023) · Cells · doi:10.3390/cells12050810 · Cited by 35
Non‐coding RNAs in cardiac hypertrophy
Ottaviani, L., & Martins, P. A. D. C. (2017) · The Journal of Physiology · doi:10.1113/jp273129 · Cited by 33
“Overexpression of CHAST in mice is sufficient to induce cardiomyocyte hypertrophic growth, while its silencing allows for both prevention and reversal of pressure overload-induced pathological cardiac remodelling (Viereck et al. 2016).”
BackgroundInfluentialFan, J., Zhang, X., Nie, X., Li, H., Yuan, S., Dai, B., Zhan, J., Zheng, W., Jiang, J., Chen, C., et al. (2019) · Science China Life Sciences · doi:10.1007/s11427-018-9515-1 · Cited by 34
“Despite significant advances in pharmacologic treatment for cardiac remodeling by β-adrenergic receptor blocking agents (β-blockers), angiotensin-converting enzyme inhibitors (ACE inhibitors), and mineralocorticoid receptor blockers (MRBs), the prognosis of patients with heart failure remains poor (Viereck et al., 201…”
BackgroundNovel Biomarkers in Heart Failure: New Insight in Pathophysiology and Clinical Perspective
Biasucci, L. M., Maino, A., Grimaldi, M. C., Cappannoli, L., & Aspromonte, N. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132771 · Cited by 35
“CHAST Cardiac remodelling (TAC in mouse and human AoS) Regulation of autophagy and hypertrophy Myocardial biopsy [84]”
BackgroundMethodEpigenome alterations in aortic valve stenosis and its related left ventricular hypertrophy
Gošev, I., Zeljko, M., Đurić, Ž., Nikolić, I., Gošev, M., Ivčević, S., Bešić, D., Legčević, Z., & Paić, F. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0406-7 · Cited by 36
“reported a significant upregulation of CHAST (cardiac hypertrophy-associated lncRNA transcript) lncRNA in hypertrophic heart tissue from AS patients and in human embryonic stem cellderived cardiomyocytes upon hypertrophic stimuli [102].”
BackgroundRoles of long noncoding RNAs in aging and aging complications
Jin, L., Song, Q., Zhang, W., Geng, B., & Cai, J. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.09.021 · Cited by 33
Pant, T., Dhanasekaran, A., Bai, X., Zhao, M., Thorp, E. B., Forbess, J. M., Bosnjak, Z. J., & Ge, Z. (2019) · Scientific Reports · doi:10.1038/s41598-019-51872-9 · Cited by 32
Magadum, A., Singh, N., Kurian, A. A., Sharkar, M. T. K., Sultana, N., Chepurko, E., Kaur, K., Żak, M. M., Hadas, Y., Lebeche, D., et al. (2021) · Advanced Science · doi:10.1002/advs.202004661 · Cited by 34
Zhao, Y., Riching, A. S., Knight, W. E., Chi, C., Broadwell, L. J., Du, Y., Abdel-Hafiz, M., Ambardekar, A. V., Irwin, D. C., Proenza, C., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.058017 · Cited by 28
Reprogramming Interferon Regulatory Factor Signaling in Cardiometabolic Diseases
Zhang, Y., & Li, H. (2017) · Physiology · doi:10.1152/physiol.00038.2016 · Cited by 34
“93) and long noncoding RNA (lncRNA)-mediated signaling (95, 97, 103), and induce immune and inflammatory responses.”
The role of long non-coding RNAs in cardiac development and disease
García‐Padilla, C., Aránega, A. E., & Franco, D. (2018) · Global Medical Genetics · doi:10.3934/genet.2018.2.124 · Cited by 30
Gomes, C. P. C., de Gonzalo‐Calvo, D., Toro, R., Fernandes, T. M., Theisen, D., Wang, D., Devaux, Y., & on behalf of the Cardiolinc™ network (2018) · Clinical Science · doi:10.1042/cs20171463 · Cited by 32
Exploring the read-write genome: mobile DNA and mammalian adaptation
Shapiro, J. A. (2017) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2016.1226748 · Cited by 30
“, 2014) Cardiovascular development (Klattenhoff et al., 2013; Kurian et al., 2015; Ounzain et al., 2015; Viereck et al., 2016) Muscle development (Neguembor et al.”
BackgroundCombining cell and gene therapy to advance cardiac regeneration
Marotta, P., Cianflone, E., Aquila, I., Vicinanza, C., Scalise, M., Marino, F., Mancuso, T., Torella, M., Indolfi, C., & Torella, D. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1430762 · Cited by 31
Ye, D., Bao, Z., Yang, Y. P., Han, Z., Yu, Y., Xu, Z., Ma, W., Yuan, Y., Zhang, L., Xu, Y., et al. (2020) · Toxicology · doi:10.1016/j.tox.2020.152422 · Cited by 31
Chen, C., Zong, M., Lü, Y., Guo, Y., Lv, H., Xie, L., Fu, Z., Cheng, Y., Si, Y., Ye, B., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15740 · Cited by 32
Dietary essential amino acids for the treatment of heart failure with reduced ejection fraction
Ragni, M., Greco, C. M., Felicetta, A., Ren, S. V., Kunderfranco, P., Ruocco, C., Carullo, P., Larcher, V., Tedesco, L., Severi, I., et al. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad005 · Cited by 33
“Although HL-1 cells are not ideal for studying cardiomyocytes metabolism, they are, however, widely used to study cardiomyocyte hypertrophy in vitro.(24) Endothelin-1 (ET-1) (100 nM in DMSO) (Sigma-Aldrich) was added to cells (80–90% confluent) that were previously deprived for 48 hr of norepinephrine and then serum-s…”
BackgroundLncRNA CHKB-DT Downregulation Enhances Dilated Cardiomyopathy Through ALDH2
Nie, X., Fan, J., Dai, B., Zheng, W., Li, H., Chen, C., & Wang, D. W. (2024) · Circulation Research · doi:10.1161/circresaha.123.323428 · Cited by 31
Regulation of Cholesterol Homeostasis by a Novel Long Non-coding RNA LASER
Li, C., Hu, Z., Zhang, W., Yu, J., Yang, Y., Xu, Z., Luo, H., Liu, X., Liu, Y., Chen, C., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-44195-2 · Cited by 32
Current RNA strategies in treating cardiovascular diseases
Chia, S. P. S., Pang, J. K. S., & Soh, B.-S. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.01.028 · Cited by 34
RNA Therapeutics for Treatment of Cardiovascular Diseases: Promises and Challenges
Lucas, T., & Dimmeler, S. (2016) · Circulation Research · doi:10.1161/circresaha.116.308730 · Cited by 30
Beermann, J., Kirste, D., Iwanov, K., Lu, D., Kleemiß, F., Kumarswamy, R., Schimmel, K., Bär, C., & Thum, T. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.158 · Cited by 30
“gov/refseq/) in 2013 (Cellecta, Mountain View, CA, USA), from the top 50 hits from microarray lncRNA analysis of Viereck et al.(35) and unpublished data and from lists of ultraconserved elements.”
BackgroundSelf-citationLncRNAs in cardiac hypertrophy: From basic science to clinical application
Liu, L., Zhang, D., & Li, Y. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15819 · Cited by 29
Yu, F., Bao, Y., Ding, J., Li, H., Liu, W., Wang, X., Guan, H., & Chen, Z. (2022) · Bioengineered · doi:10.1080/21655979.2022.2033380 · Cited by 35
Long Noncoding RNA: Genomics and Relevance to Physiology
Kong, Y., Lu, Z., Liu, P., Liu, Y., Wang, F., Liang, E. Y., Hou, F. F., & Liang, M. (2019) · Comprehensive physiology · doi:10.1002/cphy.c180032 · Cited by 30
Han, D. H., Gao, Q., & Cao, F. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.02.024 · Cited by 29
Sun, Y., Fan, W., Xue, R., Dong, B., Liang, Z., Chen, C., Li, J., Wang, Y., Zhao, J., Huang, H., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13173 · Cited by 28
“inhibition and cardiomyocyte hypertrophy.(8) Additionally, studies have identified several lncRNAs, such as cardiac hypertrophy related factor,(9) H19,(10) large intergenic non-coding RNA ROR,(11) metastasis-associated lung adenocarcinoma transcript 1,(12) HOX transcript antisense RNA,(13) and myocardial infarction as…”
BackgroundExpression of NF-κB associated lncRNAs in schizophrenia
Safa, A., Badrlou, E., Arsang‐Jang, S., Sayad, A., Taheri, M. N., & Ghafouri‐Fard, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-75333-w · Cited by 28
Long noncoding RNAs: emerging roles in pulmonary hypertension
Jin, Q., Zhao, Z., Zhao, Q., Yu, X. L., Yan, L., Zhang, Y., Luo, Q., & Liu, Z. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09866-2 · Cited by 28
Huang, Y., Liu, H., Guo, R., Han, Y., Yang, Y., Zhao, Y. D., Zheng, Y., Jia, L., & Li, W. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.631181 · Cited by 32
“, 2019), tumorigenesis, cardiovascular disease (Lorenzen and Thum, 2016; Viereck et al., 2016), and diabetes.”
McMullen, J. R., & Drew, B. G. (2016) · Clinical Science · doi:10.1042/cs20160244 · Cited by 31
Long Non-Coding RNAs in Vascular Inflammation
Haemmig, S., Simion, V., & Feinberg, M. W. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00022 · Cited by 28
“Because the expression of some lncRNAs track with stage-specific pathophysiological processes and they can be measured in serum (68), lncRNAs provide new avenues for diagnostics.”
BackgroundGidlöf, O., Bader, K., Celik, S., Grossi, M., Nakagawa, S., Hirose, T., Metzler, B., Olde, B., & Erlinge, D. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02854-7 · Cited by 29
Epigenetic therapies in heart failure
Alexanian, M., Padmanabhan, A., McKinsey, T. A., & Haldar, S. M. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.04.012 · Cited by 27
The roles of long noncoding RNAs in myocardial pathophysiology
Chen, C., Tang, Y., Sun, H., Lin, X., & Jiang, B. (2019) · Bioscience Reports · doi:10.1042/bsr20190966 · Cited by 26
García‐Padilla, C., Dominguez, J. N., Aránega, A. E., & Franco, D. (2019) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2019.194435 · Cited by 26
The Role of Long Non-Coding RNAs in Cardiovascular Diseases
Le, L. T. T., & Nhu, C. X. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813805 · Cited by 29
“24 CHAST NA Plekhm1 Downregulates Plekhm1 to induce the cardiac remodeling processes [68]”
Cao, H., Yang, B., Zhao, Y., Deng, X., & Shen, X. (2020) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-20-545 · Cited by 27
“Other studies from high-throughput screening and global lncRNA expression profiling have identified some altered lncRNAs in myocardial tissue during cardiac remodeling (23,24).”
BackgroundLong non-coding RNAs in coronary atherosclerosis
Wang, Y., Song, X., Li, Z., & Liu, B. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.08.072 · Cited by 28
Long non-coding RNAs: controversial roles in drug resistance of solid tumors mediated by autophagy
Saadh, M. J., Almoyad, M. A. A., Arellano, M. T. C., Maaliw, R. R., III, Castillo-Acobo, R. Y., Jalal, S. S., Gandla, K., Obaid, M., Abdulwahed, A. J., Ibrahem, A. A., et al. (2023) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-023-04582-z · Cited by 24
“Viereck and co-workers have demonstrated that lncRNA Chast could inhibit autophagy and its consequent cardio-myocyte hypertrophy via negative regulation of Plekhm1 [50] (Fig.”
BackgroundFrom bench to bedside: The long journey of long non-coding RNAs
Bonetti, A., & Carninci, P. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.04.016 · Cited by 23
Long Non-Coding RNAs (lncRNAs) in Cardiovascular Disease Complication of Type 2 Diabetes
Ismail, N., Abdullah, N., Murad, N. A. A., Jamal, R., & Sulaiman, S. A. (2021) · Diagnostics · doi:10.3390/diagnostics11010145 · Cited by 30
Grote, P., & Boon, R. A. (2018) · Circulation Research · doi:10.1161/circresaha.118.313447 · Cited by 31
“Some interesting candidates (Chast, Wisper) are already pursued by academic spin off companies.(14,15) Now that the field of lncRNA research matures, it is time to show that they can live up to their potential.”
BackgroundCirculating Non-Coding RNAs as Indicators of Fibrosis and Heart Failure Severity
Boichenko, V., Noakes, V. M., Reilly-O’Donnell, B., Luciani, G. B., Emanueli, C., Martelli, F., & Gorelik, J. (2025) · Cells · doi:10.3390/cells14070553 · Cited by 24
“The overexpression of CHAST was found to be enough to trigger cardiomyocyte hypertrophy both in vitro and in vivo, whereas silencing CHAST mitigated the pathological cardiac remodelling caused by TAC [107].”
Pleiotropic cardiac functions controlled by ischemia-induced lncRNA H19
Hobuß, L., Foinquinos, A., Jung, M., Kenneweg, F., Xiao, K., Wang, Y., Zimmer, K., Remke, J., Just, A., Nowak, J., et al. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.07.001 · Cited by 25
Self-citationThe long non-coding RNA NRON promotes the development of cardiac hypertrophy in the murine heart
Hoepfner, J., Leonardy, J., Lu, D., Schmidt, K., Hunkler, H. J., Biß, S., Foinquinos, A., Xiao, K., Kumarswamy, R., Ramanujam, D. P., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.11.018 · Cited by 24
Self-citationLncRNAs at the heart of development and disease
Anderson, K. M., & Anderson, D. M. (2022) · Mammalian Genome · doi:10.1007/s00335-021-09937-6 · Cited by 25
Long noncoding RNA s: A new player in the prevention and treatment of diabetic cardiomyopathy?
Ma, C., Luo, H., Liu, B., Li, F., Tschöpe, C., & Fa, X. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3056 · Cited by 24
“Unlike protein‐coding genes, lncRNAs have insufficient coding capacity since they are short of a significant open reading frame (ORF) or a protein domain.(25) Also, lncRNAs display random codon usage, and there is no strong bias for silent nucleotide substitutions, highlighting its weak protein‐coding potential(26); t…”
BackgroundNoncoding RNAs regulating cardiac muscle mass
Wadley, G. D., Lamon, S., Alexander, S. E., McMullen, J. R., & Bernardo, B. C. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00904.2018 · Cited by 23
Landscape of the long non-coding RNA transcriptome in human heart
Jiang, C., Ding, N., Li, J., Jin, X., Li, X., Pan, T., Huo, C., Li, Y., Xu, J., & Li, X. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bby052 · Cited by 24
Wang, X., Wang, L., Ma, Z., Liang, W., Li, J., Li, Y., Gui, Y., & Ai, S. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.12.058 · Cited by 22
A Guide to the Short, Long and Circular RNAs in Hypertension and Cardiovascular Disease
Prestes, P. R., Maier, M. C., Woods, B. A., & Charchar, F. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103666 · Cited by 23
The long noncoding RNA landscape in cardiovascular disease: a brief update
Salamon, I., Jotti, G. S., & Condorelli, G. (2018) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000507 · Cited by 22
Adamowicz‐Brice, M., Morgan, C. C., Haubner, B. J., Noseda, M., Collins, M. J., Paiva, M. S. A., Srivastava, P. K., Gellert, P., Razzaghi, B., O’Gara, P., et al. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.117.001805 · Cited by 24
Evolutionary Patterns of Non-Coding RNA in Cardiovascular Biology
Gandhi, S., Rühle, F., & Stoll, M. (2019) · Non-Coding RNA · doi:10.3390/ncrna5010015 · Cited by 22
Turton, N., Swan, R., Mahenthiralingam, T., Pitts, D., & Dykes, I. M. (2019) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd6020021 · Cited by 24
“In vivo GapmeR-based silencing of CHAST prevented pathological remodelling in the mouse model [106].”
BackgroundDysregulation of NF-κB-Associated lncRNAs in Multiple Sclerosis Patients
Safa, A., Arsang‐Jang, S., Taheri, M. N., Omrani, M. D., & Ghafouri‐Fard, S. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01628-2 · Cited by 19
“The cardiac hypertrophy–associated transcript (Chast) is involved in the process of cardiac remodeling through obstructing cardiomyocyte autophagy and inducing hypertrophy (Viereck et al. 2016).”
BackgroundCirculating Circular RNAs: Novel Biomarkers for Heart Failure
Sun, C., Ni, M.-M., Song, B., & Cao, L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.560537 · Cited by 20
Non-coding RNA and their potential role in cardiovascular diseases
Samra, M., & Srivastava, K. (2022) · Gene · doi:10.1016/j.gene.2022.147011 · Cited by 20
Metadata
- Authors
- Viereck, J., Kumarswamy, R., Foinquinos, A., Xiao, K., Avramopoulos, P., Kunz, M., Dittrich, M., Maetzig, T., Zimmer, K., Remke, J., Just, A., Fendrich, J., Scherf, K., Bolesani, E., Schambach, A., Weidemann, F., Zweigerdt, R., de Windt, L. J., Engelhardt, S., Dandekar, T., Batkai, S., & Thum, T.
- Affiliations
- Medizinische Hochschule Hannover (DE)
- German Centre for Cardiovascular Research (DE)
- University of Würzburg (DE)
- Department of Cardiology, Maastricht University, 6202 AZ Maastricht, Netherlands.
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Integriertes Forschungs- und Behandlungszentrum Transplantation (IFB-Tx), Hannover Medical School, D-30625 Hannover, Germany.
- Corresponding author
- Viereck, Janika
- Kumarswamy, Regalla
- Foinquinos, Ariana
- Thum, Thomas
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2016-02-17
- Volume
- 8
- Issue
- 326
- Pages
- 326ra22-326ra22
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2283987082
- Cited by
- 370
- References
- 44
- Citations by year
- 2026: 15 · 2025: 16 · 2024: 20 · 2023: 35 · 2022: 35 · 2021: 32 · 2020: 58 · 2019: 56 · 2018: 45 · 2017: 43 · 2016: 15
- FWCI
- 43.72
- Type
- journal article
- Language
- en
- Open access
- green
- zenodo.org
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion)
- Funders
- Integrierte Forschungs- und Behandlungszentrum Transplantation (BMBF 01EO1302)
- Deutsche Forschungsgemeinschaft (TH 903/10-1, RE 3523/1-1)
- REBIRTH Excellence Cluster
- Fondation Leducq
- European Research Council
- Hannover Biomedical Research School
- Bayerische Forschungsstiftung
- German Research Foundation (EXC62/3, ZW 64/4-1)
- German Ministry for Education and Science (13N12606)
- Innovative Medicines Initiative (115439-2)
- European Union (FP7/2007-2013)
- European Federation of Pharmaceutical Industries and Associations
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- long non-coding RNA, cardiac remodeling, cardiomyocyte hypertrophy, pressure overload, transverse aortic constriction, aortic stenosis, autophagy, PLSCR1, lncRNA expression profiling, heart disease
- MeSH terms
- Animals, Base Sequence, Gene Expression Regulation, Cardiomegaly, Humans, Male, Mice, Inbred C57BL, Molecular Sequence Data, Pressure, Signal Transduction, Ventricular Remodeling, Myocytes, Cardiac, NFATC Transcription Factors, Translational Research, Biomedical, RNA, Long Noncoding
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.